WOMENZHIDAO，FEIPANGHEFEIJIUJINGXINGZHIFANGGANJIBING（NAFLD）DEFABINGLVZAIBUDUANZENGJIA，SUIRANTONGCHANGZAIFEIPANGHUANZHEZHONGGANZHIFANGBIANXINGGENGRONGYIFASHENG，DANDUIYUMEIYOUDIANXINGWEIXIANYINSUDESHOUROUHUANZHE，GANZHIFANGBINGBIANSHIFOUYEHUIFASHENGNI，ZHEIYOUDAIJINYIBUDETANJIU。YINCI，ZAIBENXIANGYANJIUZHONGYANJIURENYUANZHIZAIQUEDINGZAITISHOUHUANZHEZHONGGANZHIFANGBIANXINGDEFASHENGLVHEWEIXIANYINSU。

　　YANJIURENYUANHUIGUXINGSHOUJIWEIFASHENGBINGDUXINGGANYANQIEBMI≤25 kg/m2DETISHOUHUANZHE，TONGGUOSHUNSHIDANXINGCHENGXIANGJINXINGGANYINGDUCELIANG（LSM）HESHOUKONGSHUAIJIANCANSHU（CAP）DECELIANG。

　　ZUIHOUYOU218MINGHUANZHEBEINARUBENXIANGYANJIU，QIZHONG34.5%DEHUANZHEXIANSHICHUGANZHIFANGBIANXING（CAP≥268FENBEI/MI），GANZHIFANGBIANXINGHUANZHEDE GUXIANZHUANTAIMEI(GGT) JIAOGAO（238.0 vs.112.1IU/mL; p= 0.013），AST（63（±67.4）vs.38.5（±32.9）IU / mL; p ?= 0.001）HEALT（59.1（±58.8）vs. 44.3（±52.7）IU / mL; p ?= 0.048）YEJUNJIAOGAO，BINGXIANSHIQUYUGENGYANZHONGDEXIANWEIHUADEQUSHI（LSM 15.6（±19.5）vs. 12.0（±15.7）kPa; p?= 0.115），ZAIDUOYUANHUIGUIFENXIZHONG，ZHIYOUXUEQINGNIAOSUANSHUIPINGYUGANZHIFANGBIANXINGDULIXIANGGUAN（ORWEI1.43 /MEIDANWEImg / dL； 95％CI 1.001–2.054；p = 0.049）。ZAI38.9GEYUEDEPINGJUNSUIFANGQIJIAN，14LIHUANZHE（5.0％）SIWANG。ZAIMEIYOUWANQIXIANWEIHUADEQINGKUANGXIA，WUZHIFANGBIANXING（98.7％）HEZHIFANGBIANXING（98.6％）DEHUANZHEZAI1NIANHOUDECUNHUOLVXIANGSI。

　　ZUIHOUYANJIURENYUANSHUODAO：XUEQINGNIAOSUANSHUIPINGGAOHUIZENGJIASHOUHUANZHEGANZHIFANGBIANXINGDEFENGXIAN。GANXIANWEIHUAERFEIGANZHIFANGBIANXINGSHISHOURUOHUANZHESHENGCUNSHOUSUNDEWEIXIANYINSU。

　　YUANSHICHUCHU：

　　Lukas W. Unger. Et al. Hepatic Steatosis in Lean Patients： Risk Factors and Impact on Mortality. Digestive Diseases and Sciences.2020.